These AI breakthroughs aren’t just cool—they might be the first steps toward true human-level intelligence.

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

The decision to end the service was ultimately made by the US Department of Defense (DoD) and affects data collected by the ...

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Demonstrators gathered outside Google DeepMind's London office on Monday to accuse the company of reneging on a key AI ...

Activists staged a mock courtroom outside Google DeepMind, accusing the tech giant of backtracking on its AI safety pledge ...

Google's DeepMind launches AlphaGenome, an artificial intelligence model that predicts gene expression from DNA sequence.

An artificial intelligence (AI) model developed by Google DeepMind in London could help scientists to make sense of this ...

Google DeepMind is rolling out an on-device version of its Gemini Robotics AI model that allows it to operate without an ...